PATSALI, Petros, MUSSOLINO, Claudio, LADAS, Petros, FLOGA, Argyro, KOLNAGOU, Annita, CHRISTOU, Soteroula, SITAROU, Maria, ANTONIOU, Michael N., CATHOMEN, Anton, LEDERER, Carsten W. und KLEANTHOUS, Marina, 2020. The scope for thalassemia gene therapy by disruption of aberrant regulatory elements. Freiburg: Universität.

Patsali, P., Mussolino, C., Ladas, P., Floga, A., Kolnagou, A., Christou, S., Sitarou, M., Antoniou, M.N., Cathomen, A., Lederer, C.W., Kleanthous, M., 2020. The scope for thalassemia gene therapy by disruption of aberrant regulatory elements. Universität, Freiburg. https://doi.org/10.3390/jcm8111959

Patsali, P., Mussolino, C., Ladas, P., Floga, A., Kolnagou, A., Christou, S., Sitarou, M., Antoniou, M. N., Cathomen, A., Lederer, C. W., & Kleanthous, M. (ca. 2020). The scope for thalassemia gene therapy by disruption of aberrant regulatory elements [Cd]. Universität. https://doi.org/10.3390/jcm8111959

Patsali P, Mussolino C, Ladas P, Floga A, Kolnagou A, Christou S, Sitarou M, Antoniou MN, Cathomen A, Lederer CW, Kleanthous M (2020) The scope for thalassemia gene therapy by disruption of aberrant regulatory elements. Universität, Freiburg

Patsali, Petros/ Mussolino, Claudio/ Ladas, Petros/ Floga, Argyro/ Kolnagou, Annita/ Christou, Soteroula/ Sitarou, Maria/ Antoniou, Michael N./ Cathomen, Anton/ Lederer, Carsten W./ Kleanthous, Marina, The scope for thalassemia gene therapy by disruption of aberrant regulatory elements, Freiburg 2020.